Your browser doesn't support javascript.
loading
Microglial phagolysosome dysfunction and altered neural communication amplify phenotypic severity in Prader-Willi Syndrome with larger deletion.
Correa-da-Silva, Felipe; Carter, Jenny; Wang, Xin-Yuan; Sun, Rui; Pathak, Ekta; Kuhn, José Manuel Monroy; Schriever, Sonja C; Maya-Monteiro, Clarissa M; Jiao, Han; Kalsbeek, Martin J; Moraes-Vieira, Pedro M M; Gille, Johan J P; Sinnema, Margje; Stumpel, Constance T R M; Curfs, Leopold M G; Stenvers, Dirk Jan; Pfluger, Paul T; Lutter, Dominik; Pereira, Alberto M; Kalsbeek, Andries; Fliers, Eric; Swaab, Dick F; Wilkinson, Lawrence; Gao, Yuanqing; Yi, Chun-Xia.
Afiliación
  • Correa-da-Silva F; Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC. University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
  • Carter J; Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands.
  • Wang XY; Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands.
  • Sun R; Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
  • Pathak E; Neuroscience and Mental Health Innovation Institute, MRC Centre for Neuropsychiatric Genetic and Genomics, School of Medicine, Cardiff University, Cardiff, UK.
  • Kuhn JMM; Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.
  • Schriever SC; Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.
  • Maya-Monteiro CM; Computational Discovery Unit, Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Jiao H; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Kalsbeek MJ; Research Unit NeuroBiology of Diabetes, Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Moraes-Vieira PMM; Computational Discovery Unit, Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Gille JJP; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Sinnema M; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Stumpel CTRM; Research Unit NeuroBiology of Diabetes, Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Curfs LMG; Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC. University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
  • Stenvers DJ; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
  • Pfluger PT; Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC. University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
  • Lutter D; Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands.
  • Pereira AM; Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands.
  • Kalsbeek A; Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
  • Fliers E; Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC. University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
  • Swaab DF; Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands.
  • Wilkinson L; Laboratory of Immunometabolism, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, São Paulo, Brazil.
  • Gao Y; Department of Clinical Genetics, Amsterdam University Medical Centers, location VUMC. University of Amsterdam, Amsterdam, The Netherlands.
  • Yi CX; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
Acta Neuropathol ; 147(1): 64, 2024 03 31.
Article en En | MEDLINE | ID: mdl-38556574
ABSTRACT
Prader-Willi Syndrome (PWS) is a rare neurodevelopmental disorder of genetic etiology, characterized by paternal deletion of genes located at chromosome 15 in 70% of cases. Two distinct genetic subtypes of PWS deletions are characterized, where type I (PWS T1) carries four extra haploinsufficient genes compared to type II (PWS T2). PWS T1 individuals display more pronounced physiological and cognitive abnormalities than PWS T2, yet the exact neuropathological mechanisms behind these differences remain unclear. Our study employed postmortem hypothalamic tissues from PWS T1 and T2 individuals, conducting transcriptomic analyses and cell-specific protein profiling in white matter, neurons, and glial cells to unravel the cellular and molecular basis of phenotypic severity in PWS sub-genotypes. In PWS T1, key pathways for cell structure, integrity, and neuronal communication are notably diminished, while glymphatic system activity is heightened compared to PWS T2. The microglial defect in PWS T1 appears to stem from gene haploinsufficiency, as global and myeloid-specific Cyfip1 haploinsufficiency in murine models demonstrated. Our findings emphasize microglial phagolysosome dysfunction and altered neural communication as crucial contributors to the severity of PWS T1's phenotype.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Prader-Willi Límite: Animals / Humans Idioma: En Revista: Acta Neuropathol Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Prader-Willi Límite: Animals / Humans Idioma: En Revista: Acta Neuropathol Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos